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Objective. In this study, we have assessed sympathovagal imbalance (SVI) by spectral analysis of heart rate variability (HRV) that
contributes to the genesis of early-onset PIH. Methods. Body mass index (BMI), basal heart rate (BHR), blood pressure (BP) and
HRV indices such as LFnu, HFnu, LF-HF ratio, mean RR, SDNN and RMSSD were assessed in normal pregnant women (Control
group) and pregnant women having risk factors for PIH (Study group) at all the trimesters pregnancy. Retrospectively, those
who did not develop PIH (Study group I) were separated from those who developed PIH (Study group II). Study group II was
subdivided into early-onset and late-onset PIH. Sympathovagal balance (LF-HF ratio) was correlated with BMI, BHR and BP.
Results. LF-HF ratio was signiﬁcantly high in study group II compared to study group I and control group, and in early-onset PIH
group compared to the late-onset category at all the trimesters of pregnancy, which was signiﬁcantly correlated with BHR and BP.
Alteration in HFnu in early-onset category was more prominent than the alteration in LFnu. Conclusion. Though the SVI in PIH
is contributed by both sympathetic overactivity and vagal withdrawal, especially in early-onset type, SVI is mainly due to vagal
inhibition.
1.Introduction
Hypertensive disorders of pregnancy contribute signiﬁcantly
to still births and neonatal and maternal morbidity and
mortality, especially in developing countries of south-east
Asia [1]. In India, pregnancy-induced hypertension (PIH)
accounts for about 50,000 deaths a year [2]. The major
cause of maternal and fetal deaths in PIH is due to its
late diagnosis and inadequate treatment. The clinical and
laboratory characteristics of hypertension associated with or
induced by pregnancy are diﬃcult to diﬀerentiate from those
of hypertension independent of pregnancy [3]. Pregnancy
may induce hypertension in women who are normotensive
before pregnancy and may aggravate hypertension in those
who are hypertensive before pregnancy [4]. As a result, usu-
ally precarious delay occurs in the initiation of appropriate
treatment for PIH.
Though the etiology of PIH is not exactly known, it has
been well established that the disease is characterized by
low circulating volume and high vascular resistance [5, 6].
Usually, two physiological factors that largely contribute to
the genesis of hypertension are decreased size of the vascular
compartment (vasoconstriction) and increase volume of the
compartment (increased blood volume) [7]. However, in
this dysfunction, hypertension develops inspite of low blood
volume, which clearly indicates that the primary contributor
to PIH is intense vasoconstriction induced by sympathetic
overreactivity [6]. Recent reports from our laboratory con-
ﬁrmed that detection of subtle increase in sympathetic tone
by spectral HRV analysis in the ﬁrst trimester of pregnancy
in women with high risks for PIH predicts the development
of PIH in these women that clinically manifests in third
trimester of pregnancy [8, 9].2 International Journal of Hypertension
Though, PIH usually develops in the later part of third
trimester of pregnancy, especially towards term, in some
patients disease manifests early, before completion of 34th
week of pregnancy (early-onset PIH), and often in them
the disease progresses rapidly [4]. Therefore, unless repeated
screening is performed at short intervals in this early-onset
category, patient reports in the advanced stage of the disease
that creates diﬃculty in the management of this dysfunction.
To the best of our knowledge, no report is available yet to
assess the nature of alteration in sympathovagal balance that
leads to the causation of early-onset PIH. Therefore, in the
present study we have performed spectral analysis of HRV
to understand the pathophysiology of early-onset PIH that
may help develop measures to prevent the occurrence of this
common dysfunction.
2. Methods
The present study was conducted in the Department of
Physiology, Jawaharlal Institute of Postgraduate Medical
EducationandResearch(JIPMER),Pondicherry,India.After
obtaining approval of the project plan from research and
ethics committees of JIPMER, 234 subjects (50 in control
group, 184 in study group) were recruited from the outpa-
tient unit of the obstetrics and gynecology department of
JIPMER.Writteninformedconsentwasobtainedfromallthe
participants prior to initiation of the study. Subjects of study
group included pregnant women who had at least any one
of the established risk factors for PIH [10]s u c ha sp r e v i o u s
history of pre-eclampsia, extremes of reproductive age, ﬁrst
pregnancy, diabetes mellitus, pre-existing hypertension, and
multiple pregnancy, Subjects of control group included
pregnant ladies who had none of the above-mentioned risk
factors for PIH.
Twelve subjects in the control group and seven subjects
in the study group did not turn up for second and third
trimester recordings. Therefore, these subjects were excluded
from the study. Rest all subjects (38 in the control group
and 177 in the study group) attended obstetrics OPD at all
three trimesters of pregnancy and also reported to polygraph
laboratory for recording of various parameters. All subjects
were followed up till term and any incidence of PIH was
recorded. Out of 177 study subjects, 31 developed PIH
during their course of pregnancy and were included in the
study group. Study group subjects were further divided into
early-onset PIH (who developed PIH before completion of
34th week) and late-onset PIH (who developed PIH after
completion of 34th week) based on the criteria of our
hospital and others [4].
SubjectswereadvisedtocometoobstetricsOPDforthree
antenatal check-ups during their pregnancy and from OPD
they were instructed to report to polygraph laboratory of
physiology department for recording of various parameters
during each check-up. Accordingly, three recordings were
performed on all subjects at diﬀerent gestational periods;
the 1st recording at completion of 1st trimester (towards
the end of 12th week), the 2nd recording at completion
of 2nd trimester (towards the end of the 24th week),
and the 3rd recoding at the end of the 31st week (as
previous records of Obstetrics and Gynecology Department
of JIPMER indicated that PIH usually occurs between the
32nd weeks and term). The subjects reported to polygraph
laboratory about two hours after a light breakfast devoid of
coﬀee or tea. Height and weight were measured to calculate
body mass index (BMI). Blood pressure (BP) was recorded
using Colin PressMate 8800 (Colin Corporation, Japan)
noninvasive blood pressure monitor.
Following 10 minutes of supine rest in polygraph
laboratory (room temp maintained at 25◦C), basal heart
rate (BHR), systolic blood pressures (SBP), and diastolic
blood pressure (DBP) were recorded. For recording of short-
term HRV, recommendation of the Task Force on HRV
was followed [11]. For the purpose, ECG electrodes were
connected and Lead II ECG was acquired at a rate of 1000
samples/second during supine rest using BIOPAC MP 100
data acquisition system (BIOPAC Inc., USA). The data was
transferred from BIOPAC to a windows-based PC with
Acqknowledge software version 3.8.2. Ectopics and artifacts
were removed from the recorded ECG. RR tachogram was
extracted from the edited 256 sec ECG using the R wave
detector in the Acqknowledge software and saved in ASCII
format which was later used oﬄine for short-term HRV
analysis. HRV analysis was done using the HRV analysis
software version 1.1 (Biosignal Analysis group, Finland).
Mean RR was measured in second(s). Variance, deﬁned as
power in a portion of the total spectrum of frequencies
was measured in milliseconds squared (ms2). Diﬀerent
frequency domain indices such as total power (TP), low-
frequency component expressed as normalized unit (LFnu),
high-frequency component expressed as normalized unit
(HFnu) and LF/HF ratio, and time domain indices such as
mean RR, standard deviation of normal to normal intervals
(SDNN) and square root of the mean squared diﬀerences
of successive normal to normal intervals (RMSSD) of HRV
were calculated. All subjects were followed up till term and
any incidence of PIH (DBP 90mmHg or above or SBP
140mmHg or above or both) was recorded [3, 4].
2.1. Statistical Analysis. T h eS P S Sv e r s i o n1 3w a su s e df o r
statistical analysis. All the data were expressed as mean ± SD.
One-way ANOVA with Tukey-Kramer post hoc was used in
analyzing data between the three groups and across the three
diﬀerent weeks within the groups. Student’s unpaired t test
was used to detect the level of signiﬁcance between early-
onset and late-onset PIH groups. The association between
LF-HF ratio with BMI, BHR, and blood pressures was
assessed by Pearson correlation analysis. The P-values less
than .05 were considered signiﬁcant.
3. Results
Two-hundred ﬁfteen subjects (38 control subjects and 177
subjects having risk factor for PIH) attended obstetrics
OPD regularly and also reported to polygraph laboratory
at all three trimesters of pregnancy for recording of various
parameters. Out of 177 women having risk factors for PIH,International Journal of Hypertension 3
31 (17.51%) developed PIH (Study group II). However, two
subjects developed PIH before the 31st week of pregnancy
and therefore, they do not have the 31st week recordings
(n = 29 at the 31st week). All other subjects developed PIH
between the 32nd week and term. The 146 subjects who had
risk factors for PIH, but did not develop PIH, were included
in study group I.
3.1. General Parameters. There was no signiﬁcant diﬀerence
in age between the subjects of control group and study
groups (Table 1) .T h eb o d yw e i g h ta n dB M Io fs u b j e c t so f
study group II (those who developed PIH) was signiﬁcantly
more than that of the study group I (those who did not
develop PIH) and control group at all the three gestational
weeks of recordings. However, increase in body weight and
BMI of subjects of control group and study group I, but not
of the subjects of study group II was statistically signiﬁcant
at the 31st week recording compared to their own 12th week
recording.
The basal heart rate (BHR) of the subjects of study group
II was signiﬁcantly more at all the three trimesters compared
to the subjects of control and study group I, though the
general level of signiﬁcance was reduced sequentially from
the 12th week (P<. 0001) to the 31st week (P = .0096)
(Table 1). Yet, in control group and study group I, but not
in study group II, the increase in BHR at the 31st week was
highly signiﬁcant compared to their own 12th and 24th week
values.
The SBP study group II was signiﬁcantly more than that
of the study group I and control group (P<. 001) at all
the three trimesters of pregnancy, whereas SBP of study
group I was signiﬁcantly more than that of the control group
(P<. 01) only at 31st week. The increase in SBP of study
groups I and II, but not of the control group at the 31st week
was signiﬁcantly higher compared to their own 12th week
recording (Table 1).
The DBP of study group II was signiﬁcantly more than
that of the study group I and control group at all the three
trimesters of pregnancy. The increase in DBP of study group
I and II, but not of the control group at the 31st week was
signiﬁcantly higher compared to their own 12th and 24th
week recordings. Also, the DBP of study group II at the 24th
weekwassigniﬁcantlymore(P<. 05)thanitsown12thweek
recording (Table 1).
3.2. Frequency Domain Indices of HRV. Total power (TP)
of HRV spectrum was reduced signiﬁcantly in study group
II in comparison to study group I and control group at
all the trimesters of pregnancy (Table 2), whereas reduction
in TP in study group I compared to that of control
group was signiﬁcant only at the 31st week. However, the
reduction in TP at the 31st week in study group I was
statistically signiﬁcant compared to its own 24th and 12th
week recordings.
The LFnu of study group II was signiﬁcantly higher
compared to that of control group at all the three trimesters
of pregnancy and to that of study group I at the 12th and
24th weeks of pregnancy (Table 2). However, the increase in
LFnu of control group and study group I at the 31st week,
but not the study group II compared to their own 12th week
recordings was statistically signiﬁcant.
Though the HFnu was decreased in study group II
compared to control group in all the three recordings, the
decrease was signiﬁcant (P<. 05) only at the 12th week
(Table 2). Nevertheless, only in study group I the decrease in
HFnu was statistically signiﬁcant compared to its own 12th
week recording.
The LF-HF ratio of study group II was signiﬁcantly
more compared to that of control group and study group I
at all three trimester recordings (Table 2). Nonetheless, the
increase in LF-HF ratio at the 31st week recording of control
group and study group I, but not in study group II was
signiﬁcantly higher compared to their own 12th week and
the 24th week recordings, in which the level of signiﬁcance
w a sm o r ei ns t u d yg r o u pI .
3.3. Time Domain Indices of HRV. T h ed e c r e a s ei nm e a n
RR of study group II was signiﬁcant compared to that of
control group and study group I at the 12th and 24th week
recordings (Table 2). Though the decrease in mean RR at
the 31st week compared to their own 12th and 24th week
values was signiﬁcant in control group and study group I,
the decrease was not signiﬁcant for study group II.
T h ed e c r e a s ei nS D N Ni ns t u d yg r o u pI Ic o m p a r e dt o
that of control group and study group I was statistically
signiﬁcant(P<. 05)onlyatthe12thweekrecording.RMSSD
in study groups I and II was decreased signiﬁcantly (P<. 05)
compared to the control group only at the 31st week. The
decrease in RMSSD in study group II at the 31st week was
signiﬁcant (P<. 05) compared to its own 12th week value.
Also,thedecreaseinRMSSDinstudygroupIatthe31stweek
was signiﬁcant compared to its own 12th week (P<. 001)
and 24th week (P<. 05) values.
3.4. Early-Onset versus Late-Onset PIH. Out of 31 PIH
subjects, 15 developed PIH before completion of 34 weeks
(those include two subjects who developed PIH before the
31st weeks), and they all were categorized as early-onset PIH,
and 16 developed PIH after completion of 34 weeks and were
classiﬁed as late-onset PIH.
3.4.1. General Parameters. There was no diﬀerence in age
between subjects of early-onset and late-onset PIH groups
(Table 3). There was no diﬀerence in body weight and BMI
between subjects of early-onset and late-onset PIH groups at
all the three trimester recordings (Table 3). Also, the increase
in body weight and BMI of subjects of both early-onset and
late-onset PIH groups at the 31st week recording was not
signiﬁcant compared to their own 12th week recording. The
BHR of early-onset group was signiﬁcantly more than the
late-onset group at all the three recordings (P = .0381 at the
12thweek, .0215atthe24thweek,and .0094atthe31stweek
recordings). Though there was no diﬀerence in SBP between
these two groups at the 12th week, SBP was signiﬁcantly
more in early-onset group compared to late-onset group at
24th (P = .0138) and 31st week recordings (P = .0350). The4 International Journal of Hypertension
Table 1: Comparison of age, body weight (BW), body mass index (BMI), heart rate (HR), systolic blood pressure (SBP), and diastolic blood
pressure (DBP) of the subjects of control group (subjects with normal pregnancy) with the subjects of study group I (those who had high
risk for PIH, but did not develop PIH) and study group II (those who developed PIH later) at diﬀerent weeks of pregnancy.
Parameters at diﬀerent
weeks
Control group
(n = 38)
Study group I
(n = 146)
Study group II
(n = 31) P-values
At 12th week
Age (yr) 24.21 ± 3.12 23.85 ± 4.15 25.30 ± 3.60 .1734
BW (kg) 49.84 ± 10.70 53.10 ± 9.70 56.80 ± 15.06∗ .0303
BMI (Kg/m2) 20.26 ± 3.98 22.05 ± 4.76 24.32 ± 8.75∗∗ .0088
BHR (per min) 74.44 ± 13.77 80.85 ± 12.80∗ 90.54 ± 15.54∗∗∗,## <.0001
SBP (mm Hg) 103.60 ± 9.32 106.30 ± 8.92 113.34 ± 10.52∗∗∗,### <.0001
DBP (mm Hg) 59.34 ± 7.78 61.05 ± 7.90 65.90 ± 7.30∗∗,## .0016
At 24th week
BW (kg) 52.81 ± 10.81 55.70 ± 10.80 60.72 ± 14.84∗ .0171
BMI (Kg/m2) 21.97 ± 4.01 23.50 ± 7.15 26.56 ± 8.20∗ .0208
BHR (per min) 78.92 ± 13.72 83.60 ± 11.70 91.24 ± 15.70∗∗∗,## .0004
SBP (mm Hg) 104.44 ± 7.92 108.40 ± 9.64 120.81 ± 13.90∗∗∗,### <.0001
DBP (mm Hg) 59.89 ± 6.14 62.56 ± 8.88 72.56 ± 10.20∗∗∗,###,f <.0001
At 31st week
BW (kg) 56.28 ± 10.81f 59.10 ± 11.84ﬀf,a 65.36 ± 16.40∗∗,# .0110
BMI (Kg/m2) 23.89 ± 4.00f 26.05 ± 5.70ﬀf,aaa 28.80 ± 8.50∗∗ .0039
BHR (per min) 87.08 ± 14.40ﬀf,a 91.30 ± 10.90ﬀf,aaa 96.24 ± 14.20∗∗ .0096
SBP (mm Hg) 104.77 ± 8.26 110.26 ± 8.80∗∗,ﬀ 128.78 ± 11.1∗∗∗,###,ﬀf <.0001
DBP (mm Hg) 62.00 ± 7.79 65.30 ± 7.92ﬀf,a 82.28 ±
10.1∗∗∗,###,ﬀf,aa <.0001
The values are mean ± SD; analysis of each parameter between the groups and across the three weeks was done by one-way ANOVA, followed by Tukey-
Kramer post-hoc. The ∗ mark indicates comparison with control group and the # mark indicates comparison with study group I. ∗P<. 05; ∗∗P<. 01;
∗∗∗P<. 001; #P<. 05; ##P<. 01; ###P<. 001. The f indicates comparison with the 12th week and the a indicates comparison with the 24th week of respective
groups. fP<. 05; ﬀfP<. 001; aP<. 05; aaP<. 01. (n = 29 in study group at the 31st week).
SBP of both the groups was signiﬁcantly more at 31st week
recording compared to their own 12th week recordings, in
which the signiﬁcance was more for early-onset (P<. 01)
compared to late-onset (P<. 05) subjects. The DBP of
early-onset group was signiﬁcantly more than the late-onset
group at all the three weeks of recordings (P = .0052 at
the 12th week, .0029 at the 24th week, and .0363 at the 31st
week recordings). Moreover, the DBP of both the groups was
signiﬁcantly more at the 31st week recording compared to
their own 12th week recordings (P<. 001) and 24th week
recordings (P<. 05).
3.4.2.HRVIndices. Thoughthetotalpowerwasconsiderably
less in early-onset group compared to late-onset group at
all the three trimesters of pregnancy, the diﬀerence was
signiﬁcant (P = .0291) only at the 12th week recording
(Table 4). Though the LFnu was consistently more in early-
onset group compared to late-onset group at all the three
trimesters of pregnancy, the diﬀerence was not statistically
signiﬁcant in any of the recordings. However, HFnu was
signiﬁcantly less in early-onset group compared to late-
onset group at second and third trimesters of pregnancy
(P = .0324 at the 24th week and .0266 at the 31st week
recordings). The LF-HF ratio was signiﬁcantly more in early-
onset group compared to late-onset group at the 12th and
31st weeks of recordings, but not at the 24th week of
recording (P = .0308 at the 12th week, .1063 at the 24th
week, and .0112 at the 31st week recordings). The mean
RR was signiﬁcantly less in early-onset group compared to
late-onset group at all the three trimesters of pregnancy
(P = .0211 at the 12th week, .0062 at the 24th week,
and .0242 atthe31st weekrecordings).Thechangein SDNN
was not signiﬁcant between the two groups at all the three
trimesters of pregnancy. The RMSSD was signiﬁcantly less in
early-onset group compared to late-onset group at the 12th
and 31st weeks of recordings, but not at the 24th week of
recording (P = .0361 at the 12th week, .0999 at the 24th
week, and .0157 at the 31st week recordings).
ForHRVindicesacrosstheweekswithinthegroups,only
RMSSD was signiﬁcantly less in the 31st week (P<. 05) in
early-onset group compared to its own 12th week recording.
3.5.CorrelationAnalysis. TheincreaseinLF-HFratioinboth
early-onset (Table 5) and late-onset (Table 6)g r o u p sw a s
signiﬁcantly correlated with BHR and DBP at the 12th week
and with all the parameters (BHR, SBP, and DBP) except
BMI at the 24th and 31st weeks, in which the signiﬁcance
was maximum for BHR and DBP at all the three weeks
of recordings. Moreover, the level of signiﬁcance was more
in early-onset compared to late-onset group for all theInternational Journal of Hypertension 5
Table 2: Comparison of age, body weight (BW), body mass index (BMI), heart rate (HR), systolic blood pressure (SBP), and diastolic blood
pressure (DBP) of the subjects of control group (subjects with normal pregnancy) with the subjects of study group I (those who had high
risk for PIH, but did not develop PIH) and study group II (those who developed PIH later) at diﬀerent weeks of pregnancy.
Parameters at diﬀerent
weeks
Control group
(n = 38)
Study group I
(n = 146)
Study group II
(n = 31) P-values
At 12th week
TP (ms2) 153.80 ± 96.09 149.90 ± 70.50 105.45 ± 75.30∗,# .0099
LFnu 42.61 ± 20.66 46.20 ± 21.76∗∗ 57.14 ± 24.10∗∗∗,# <.0001
HFnu 55.64 ± 20.90 51.90 ± 20.84 42.56 ± 21.33∗ .0295
LF/HF ratio 1.16 ± 1.04 1.21 ± 0.94 2.45 ± 2.10∗∗∗,### <.0001
Mean RR (s) 0.806 ± 0.10 0.75 ± 0.11∗ 0.665 ± 0.12∗∗∗,### <.0001
SDNN (s) 0.028 ± 0.014 0.027 ± 0.013 0.020 ± 0.013∗,# .0187
RMSSD (ms) 30.41 ± 20.54 30.07 ± 18.80 28.46 ± 18.80 .8983
At 24th week
TP (ms2) 149.50 ± 69.29 130.50 ± 60.76f 82.40 ± 52.50∗∗∗,### <.0001
LFnu 45.92 ± 20.37 50.30 ± 20.82 65.56 ± 21.70∗∗∗,### .0003
HFnu 50.07 ± 20.37 46.90 ± 20.92 40.20 ± 21.18 .1383
LF-HF ratio 1.38 ± 1.04 1.68 ± 1.05ﬀ 2.42 ± 1.90∗∗,## .0014
Mean RR (s) 0.760 ± 0.09 0.71 ± 0.09∗,ﬀ 0.657 ± 0.11∗∗∗,# <.0001
SDNN (s) 0.027 ± 0.012 0.026 ± 0.009 0.022 ± 0.009 .0685
RMSSD (ms) 28.10 ± 18.42 26.20 ± 15.80 20.32 ± 14.16 .1100
At 31st week
TP (ms2) 143.26 ± 86.53 112.84 ± 50.80∗,ﬀf,a 70.51 ± 49.33∗∗∗,## <.0001
LFnu 54.51 ± 22.83f 57.21 ± 22.60ﬀf,a 67.84 ± 23.70∗ .0415
HFnu 45.48 ± 22.83 41.40 ± 20.60ﬀf 35.65 ± 18.10 .1588
LF-HF ratio 2.01 ± 1.20ﬀ,a 2.21 ± 1.45ﬀf,aaa 3.14 ± 2.10∗∗,## .0051
Mean RR (s) 0.689 ± 0.13ﬀf,a 0.67 ± 0.13ﬀf,aa 0.624 ± 0.11 .1074
SDNN (s) 0.028 ± 0.020 0.025 ± 0.01 0.022 ± 0.010 .1433
RMSSD (ms) 27.29 ± 16.79 20.80 ± 14.90∗,ﬀf,a 18.05 ± 12.10∗,f .0240
The values are mean ± SD; analysis of each parameter between the groups and across the three weeks was done by one-way ANOVA, followed by Tukey-
Kramer post hoc. The ∗ mark indicates comparison with control group and the # mark indicates comparison with study group I. ∗P<. 05; ∗∗P<. 01;
∗∗∗P<. 001; #P<. 05; ##P<. 01; ###P<. 001. The f indicates comparison with the 12th week and the a indicates comparison with the 24th week of respective
groups. fP<. 05; ﬀfP<. 001; aP<. 05; (n = 29 in study group at the 31st week).
parameters at all the three trimesters. The correlation of LF-
HF ratio was not signiﬁcant with any of these parameters
in control group (Table 7), whereas the correlation was
signiﬁcant only with DBP at the 24th and the 31st weeks in
study group I (Table 8).
4. Discussion
In the present study, a persistently high basal heart rate
(BHR) at all the three trimesters of pregnancy in subjects of
study group II who developed PIH later in pregnancy indi-
cates that these subjects had lower vagal tone since their early
part of pregnancy, as BHR is an index of parasympathetic
activity [12]. The PIH subjects had signiﬁcantly high systolic
blood pressure (SBP) and diastolic blood pressure (DBP) in
all the three trimesters of pregnancy, which could be due
to their increased sympathetic tone as PIH is primarily a
state of sympathetic overactivity [5, 6]. SBP is the index of
cardiac output that primarily depends on the stroke volume,
whichisdeterminedmainlybyvenousreturnandmyocardial
contractility [7]. As in PIH, there is decreased blood volume,
PIH being a state of volume depletion [6, 13], increased
cardiac output in PIH is principally due to increased
myocardial contractility, which is inﬂuenced by sympathetic
activity [7]. In PIH subjects, this was further supported by
considerable increase in DBP, which is an index of peripheral
vascular resistance that reﬂects the basal sympathetic tone
[7]. Thus, the ﬁndings of the present study clearly depict the
presenceofsympatheticactivationinPIHsubjectssincetheir
1st trimester, which was further accentuated in later weeks
with the advancement of pregnancy.
LF-HF ratio, the index of sympathovagal homeostasis
represents the balance between sympathetic and parasympa-
thetic activities of the individual at any given time in resting
supine conditions [14]. Lesser values of this ratio indicate
parasympathetic dominance and greater values indicate
sympathetic dominance [14]. LF-HF ratio was signiﬁcantly
high in PIH subjects in comparison to the subjects of study
group I and control group at all the three trimesters of
recordings, reﬂecting increased sympathetic tone in these6 International Journal of Hypertension
Table 3: Comparison of age, body weight (BW), body mass index
(BMI), heart rate (HR), systolic blood pressure (SBP) and diastolic
blood pressure (DBP) between early onset PIH (before completion
of the 34 weeks) and late onset PIH (after completion of the 34
weeks).
Parameters at
diﬀ.w e e k s
Early onset PIH
(n = 15)
Late onset PIH
(n = 16) P values
At 12th week
Age 24.46 ± 4.10 25.94 ± 2.80 .2474
BW 61.20 ± 14.80 54.75 ± 13.00 .2068
BMI 25.47 ± 9.90 23.80 ± 6.17 .5746
BHR 93.96 ± 10.22 86.41 ± 9.12 .0381
SBP 117.66 ± 9.23 110.41 ± 10.68 .0531
DBP 67.50 ± 6.10 61.33 ± 5.25 .0052
At 24th week
BW 62.50 ± 18.50 58.30 ± 13.10 .4693
BMI 26.97 ± 10.20 25.13 ± 8.26 .5841
BHR 94.16 ± 9.071 86.58 ± 8.30 .0215
SBP 125.10 ± 8.10 116.66 ± 9.69 .0138
DBP 76.40 ± 7.05 67.50 ± 8.10 .0029
At 31st week
BW 67.83 ± 16.76 63.75 ± 13.32 .4711
BMI 28.90 ± 10.56 28.52 ± 7.50 .6764
BHR 100.33 ± 10.69 90.50 ± 8.24 .0094
SBP 131.80 ± 9.35ﬀ 122.33 ± 12.84f .0350
DBP 86.80 ± 13.76ﬀf,a 76.24 ± 12.04ﬀf,a .0363
The values are mean ± SD; Analysis of each parameter across the three
weeks, one-way ANOVA, followed by Tukey-Kramer post-hoc was used.
The P values depicted in the last column indicate comparison between
early-onset and late-onset PIH groups. The f indicates comparison with the
12th week and the a indicates comparison with the 24th week of respective
groups. fP<. 05; ﬀP<. 01; ﬀfP<. 001; aP<. 05;(n = 13inearly-onsetgroup
at the 31st week).
subjects. This was further evidenced by signiﬁcant increase
in LFnu in PIH subjects in comparison to other two groups
at all the three gestational weeks as LFnu mainly reﬂects
sympathetic modulation of heart functions [14]. However,
sympathovagal imbalance in PIH was also contributed by
vagal withdrawal, at least in the early part of pregnancy, as
HFnu represents vagal modulation of SA nodal discharge
[14] ,w h i c hw a sd e c r e a s e di nP I Hg r o u pc o m p a r e dt o
the control group at the 12th week of recording. Further,
signiﬁcant decrease in total power (TP) in PIH subjects
compared to control subjects at all the three trimesters
establishes the contribution of vagal withdrawal in the
development of sympathovagal imbalance, as TP in general
represents the parasympathetic potency of cardiac modula-
tion [11]. Though few earlier reports had indicated some
kind of prediction of PIH in early part pregnancy through
serial assessment of cardiovascular control [15], heart rate
and blood pressure variabilities [16], heart rate and blood
velocity variability and uterine perfusion combined with
heart rate and blood pressure variabilities [17], none of these
studieshadanalyzedthenatureanddegreeofsympathovagal
Table 4: Comparison of HRV indices between early-onset PIH and
late-onset PIH at diﬀerent weeks of gestation.
HRV indices sat
diﬀ.w e e k s
Early onset PIH
(n = 15)
Late onset PIH
(n = 16) P values
At 12th week
TP (ms2) 75.80 ± 61.20 135.90 ± 82.20 .0291
LFnu 63.42 ± 25.30 52.40 ± 20.85 .1948
HFnu 34.50 ± 16.50 47.90 ± 20.50 .0554
LF-HF ratio 2.96 ± 1.70 1.80 ± 1.10 .0308
Mean RR (s) 0.61 ± 0.13 0.71 ± 0.097 .0211
SDNN (s) 0.020 ± 0.014 0.021 ± 0.019 .8694
RMSSD (ms) 21.95 ± 13.10 36.41 ± 20.26 .0263
At 24th week
TP (ms2) 70.80 ± 60.50 118.40 ± 75.20 .0630
LFnu 67.06 ± 30.08 54.08 ± 24.41 .1961
HFnu 30.75 ± 17.34 45.95 ± 20.10 .0324
LF-HF ratio 3.05 ± 1.80 2.02 ± 1.64 .1063
Mean RR (s) 0.59 ± 0.122 0.70 ± 0.083 .0062
SDNN (s) 0.022 ± 0.011 0.022 ± 0.005 .9999
RMSSD (ms) 17.75 ± 8.01 23.96 ± 15.22 .1700
At 31st week
TP (ms2) 58.30 ± 42.65 98.70 ± 69.10 .0769
LFnu 74.46 ± 32.83 60.05 ± 28.15 .2139
HFnu 24.40 ± 15.60 39.80 ± 19.02 .0266
LF-HF ratio 3.84 ± 1.50 2.50 ± 1.15 .0112
Mean RR (s) 0.58 ± 0.11 0.67 ± 0.093 .0242
SDNN (s) 0.021 ± 0.016 0.023 ± 0.004 .6316
RMSSD (ms) 12.65 ± 6.20f 22.86 ± 13.10 .0157
Thevaluesaremean ±SD;TheP-valuesdepictedinthelastcolumnindicate
comparison between early-onset and late-onset PIH groups. The f indicates
comparison with the 12th week value of RMSSD in early-onset group. fP<
.05; (n = 13 in early-onset group at the 31st week).
Table 5: Correlation of LF-HF ratio with body mass index (BMI),
basal heart rate (HR), systolic blood pressure (SBP), and diastolic
blood pressure (DBP) of subjects of early-onset PIH group at
diﬀerent weeks of gestation.
12th week 24th week 31st week
RPrPrP
BMI 0.092 .153 0.135 .116 0.312 .085
BHR 0.770 .000 0.782 .000 0.809 .000
SBP 0.360 .052 0.374 .030 0.426 .018
DBP 0.564 .003 0.618 .001 0.694 .000
The P-values less than .05 were considered signiﬁcant.
imbalance in diﬀerent trimesters of pregnancy to elucidate
the progression and prediction of PIH.
Time domain indices such as mean-RR, SDNN, and
RMSSDaremainlytheindicatorsofparasympatheticactivity
[11]. In the present study, signiﬁcant decrease in mean-RR
in PIH subjects at the 12th and the 24th weeks recording
indicates decreased parasympathetic tone in these subjects in
the ﬁrst half of pregnancy. SDNN and RMSSD reﬂect vagalInternational Journal of Hypertension 7
Table 6: Correlation of LF-HF ratio with body mass index (BMI),
basal heart rate (HR), systolic blood pressure (SBP), and diastolic
blood pressure (DBP) of subjects of late-onset PIH group at
diﬀerent weeks of gestation.
12th week 24th week 31st week
RPrPrP
BMI 0.020 .205 0.054 .170 0.011 .110
BHR 0.570 .003 0.632 .001 0.710 .000
SBP 0.230 .090 0.284 .075 0.385 .046
DBP 0.448 .032 0.510 .010 0.610 .001
The P-values less than .05 were considered signiﬁcant.
Table 7: Correlation of LF-HF ratio with body mass index (BMI),
basal heart rate (HR), systolic blood pressure (SBP), and diastolic
bloodpressure(DBP)ofsubjectsofcontrolgroupatdiﬀerentweeks
of gestation.
12th week 24th week 31st week
RPrPrP
BMI 0.034 .245 0.020 .310 0.010 .465
BHR 0.204 .102 0.210 .095 0.240 .086
SBP 0.130 .170 0.184 .135 0.232 .090
DBP 0.118 .190 0.125 .172 0.184 .125
The P-values less than .05 were considered signiﬁcant.
Table 8: Correlation of LF-HF ratio with body mass index (BMI),
basal heart rate (HR), systolic blood pressure (SBP), and diastolic
b l o o dp r e s s u r e( D B P )o fs u b j e c t so fs t u d ygr o u pIa td i ﬀerent weeks
of gestation.
12th week 24th week 31st week
rPrPrP
BMI 0.031 .260 0.048 .235 0.018 .380
BHR 0.189 .132 0.218 .105 0.231 .092
SBP 0.096 .124 0.235 .086 0.280 .065
DBP 0.290 .071 0.312 .048 0.346 .020
The P-values less than .05 were considered signiﬁcant.
modulation of heart rate, and RMSSD is considered as an
important indicator of parasympathetic inﬂuence especially
in long-term HRV recordings [11]. Though HRV recording
in the present study is a short-term one, the signiﬁcant
decrease in RMSSD at the 31st week in study group II
indicates mild decrease in parasympathetic modulation of
SA nodal discharge towards later part of pregnancy in PIH
subjects.
Till date, to best of our knowledge, the cause of sym-
pathovagal imbalance in PIH has not been elucidated. One
could argue that higher BMI in PIH subjects has contributed
to the autonomic imbalance as increased BMI has been
reported to increase sympathetic activity [18]. However,
increase in body weight and BMI in pregnancy is mainly due
to increase in size of the growing fetus, uterus, and placenta,
and increase in ECF volume, not due to increased adiposity
[19]. Moreover, recent report from our laboratory indicates
that there is no correlation of BMI with sympathovagal
imbalance in PIH [9]. From the present study, it appears that
in normal pregnancy from ﬁrst trimester to third trimester,
there is progressive increase in sympathetic activity without
much decrease in parasympathetic activity as LFnu but not
HFnu was altered signiﬁcantly at the 31st week in control
subjects compared to their 12th week recording. Hence, PIH
was proposed to be a state of exaggeration of this increased
sympathetic activity of the normal pregnancy [5].
In the present study, there was no signiﬁcant diﬀerence
in age, body weight, and BMI between subjects of early-
onset and late-onset PIH. Signiﬁcantly high BHR, SBP
(except in the 12th week) and DBP in early-onset group
compared to the late-onset group at all three weeks of
gestation indicate higher degree sympathetic activity in
these subjects throughout pregnancy. This was conﬁrmed
by presence of signiﬁcantly high LF-HF ratio in early-onset
group compared to late-onset group in the 12th and the
31st weeks of pregnancy. Mean RR was signiﬁcantly low
in early onset group in all the three trimesters as heart
rate was signiﬁcantly high in these subjects. Signiﬁcantly
low RMSSD in early-onset group at the 12th and the
31st week indicates vagal inhibition in these subjects, as
RMSSD is a marker of vagal modulation of heart rate [11].
It appears that contribution of vagal withdrawal is more
prominent than sympathetic inhibition in the genesis of
sympathovagal imbalance in early-onset PIH, as decrease
in HFnu in early-onset subjects compared to late-onset
subjects was signiﬁcant at all the three trimesters, without
signiﬁcant increase in LFnu. This was further indicated by
a proportionate correlation of LH-FH ratio with increase
in BHR across the three trimesters of gestation in both
early-onset and late-onset groups, as BHR is an index of
vagal activity [12]. This correlation was more in early-onset
group indicating a greater vagal withdrawal in these subjects
compared to late-onset subjects. The degree of correlation
of LF-HF ratio with SBP and DBP was less signiﬁcant in
comparison to the degree of correlation with BHR indicating
thattheimpactofsympatheticoveractivityisrelativelylessin
comparison to vagal inhibition. Contribution of BMI to the
sympathovagal imbalance in both early-onset and late-onset
groups is negligible, as the correlation was not signiﬁcant for
this parameter.
Based on the report of our hospital records and others,
the patients with early-onset PIH more commonly enter
the phase of eclampsia that heralds convulsion and other
complications. Therefore, in our study we had kept all our
subjects those who had LF-HF ratio more than 2.5 at their
31st week recording under constant medical surveillance till
their delivery. Hence, none of our subject had progressed
into the eclamptic phase. Thus, it is imperative to predict
the onset of PIH in subjects having risks for PIH, especially
those who are prone for early-onset type of this dysfunction.
However, the future research should aim at elucidating the
mechanisms that contribute to vagal withdrawal in early-
onset PIH subjects.
Though the exact cause of sympathovagal imbalance
in PIH is not known, recently, it was suggested that
hypertension in pregnancy is due to release of biologically
active circulating factors such as cytokines or reactive oxygen8 International Journal of Hypertension
species from placenta (placental factors) that inhibit vascular
relaxation pathway or promote vascular smooth muscle
contraction [20]. As present study indicates sympathovagal
imbalance mainly in the form of vagal withdrawal in early-
onsetPIH,wehypothesizethattheso-calledplacentalfactors
might be acting primarily on medullary cardiovascular
centers in the brain to modulate central parasympathetic
outﬂow rather than exclusively acting peripherally on the
blood vessels to alter vascular tone, as reports indicate that
cytokines [21, 22] and reactive oxygen species [22, 23]
released peripherally cross blood-brain barrier and inﬂuence
activities of various brain centers. Also, it appears that
sympathetic overactivity in PIH is not just exaggeration of
sympathetic activation that usually occurs towards later part
of normal pregnancy [24], it is an abnormal autonomic
reaction that starts in the ﬁrst trimester with formation
of placenta. Therefore, further studies should address the
nonpharmacologicalinterventionsuchasbreathingexercises
program that are known to promote vagal tone and decrease
sympathetic activity [25], in the early part of pregnancy
in women with risk factor for PIH having signiﬁcant
sympathovagal imbalance, so that they do not progress into
the phase of hypertension.
Limitationsof the Study
The major limitation of the present study is less sample size
of early-onset and late-onset PIH groups. Also, we have not
studied the role of cytokines released from placenta such
as interleukins in the genesis of sympathovagal imbalance.
In our future studies, we plan to assess the biochemical
markers of sympathovagal imbalance in PIH in a lager
sample size. The sympathetic activity measured in this study
is not accurate. Therefore, future studies should include
moreaccuratemethodsofassessmentofsympathetic activity
such as estimation of plasma catecholamines or metabolites
ofcatecholaminesinurinelikevanillylmandelicacid(VMA),
metanephrine, and normetanephrine.
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